Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 9, 2015
Addressing changed sexual functioning in cancer patients: A cross-sectional survey among Dutch oncology nursesE M Krouwel, M P J Nicolai, A Q M J van Steijn-van Tol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatmentN I Weijl, D Van der Harst, A Brand, et al.
Bone Reports|July 10, 2023
Quantitative ultrasound of the calcaneus (QUS): A valuable tool in the identification of patients with non-metastatic prostate cancer requiring screening for osteoporosisB B Nieuwkamer, J P M Vrouwe, P M Willemse, et al.
Human Gene Therapy|April 11, 2000
Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell lineS Osanto, P P Schiphorst, N I Weijl, et al.
Journal of Cancer Research and Clinical Oncology|March 18, 2008
Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapyF J F Broeyer, S Osanto, H J Ritsema van Eck, et al.
British Journal of Cancer|May 11, 2013
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivorsP M Willemse, J Burggraaf, N A T Hamdy, et al.
British Journal of Cancer|August 8, 2013
Chemotherapy for testicular cancer induces acute alterations in diastolic heart functionL D van Schinkel, P M Willemse, R W van der Meer, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 3, 2008
[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus]P H M de Mulder, J B A G Haanen, S Sleijfer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2019
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†A Horwich, M Babjuk, J Bellmunt, et al.
Pageof 6